Status:
RECRUITING
Rett Syndrome Registry
Lead Sponsor:
International Rett Syndrome Foundation
Collaborating Sponsors:
Boston Children's Hospital
Children's Health UTSW
Conditions:
Rett Syndrome
Rett Syndrome, Atypical
Eligibility:
All Genders
Up to 99 years
Brief Summary
The Rett Syndrome Registry is a longitudinal observational study of individuals with MECP2 mutations and a diagnosis of Rett syndrome. Designed together with the IRSF Rett Syndrome Center of Excellenc...
Eligibility Criteria
Inclusion
- Male or female with a pathologic loss of function alteration of MECP2
Exclusion
- Male or female with a gain of function alteration of MECP2, including those with MEPC2 duplication or triplication
Key Trial Info
Start Date :
August 2 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2028
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT05432349
Start Date
August 2 2022
End Date
July 1 2028
Last Update
January 11 2023
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama
Birmingham, Alabama, United States, 35233
2
Children's Hospital Los Angeles
Los Angeles, California, United States, 90027
3
UCSF Benioff Children's Hospital
Oakland, California, United States, 94609
4
Children's Hospital Colorado
Denver, Colorado, United States, 80045